• EOPatch gets its first regulatory approval

  • EOPatch, the first wearable disposable insulin pump product from EOFLOW, got its first regulatory approval, from the Korean MFDS (Ministry of Food and Drug Safety). 

    EOFLOW will immediately start preceding clinical trials and plans to launch the product in Korea this coming spring.  Earlier, EOFLOW has appointed Huons (www.huons.com) as the exclusive distributor of EOPatch in the Korean market. 

We use cookies. By continuing to use our site you accept our cookie policy. Find out more about our privacy policy here